These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7211894)

  • 21. Acquired factor XII Deficiency in a patient with nephrotic syndrome.
    van Royen EA; de Boer JE; Wilmink JM; Jenkins CS; ten Cate JW
    Acta Med Scand; 1979; 205(6):535-9. PubMed ID: 452949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency and urinary losses of factor XII in adult nephrotic syndrome.
    Vaziri ND; Ngo JL; Ibsen KH; Mahalwas K; Roy S; Hung EK
    Nephron; 1982; 32(4):342-6. PubMed ID: 6820124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma prekallikrein: quantitative determination by direct activation with Hageman factor fragment (beta-XIIa).
    Alving BM; Tankersley DL; Mason BL
    J Lab Clin Med; 1983 Feb; 101(2):226-41. PubMed ID: 6549773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.
    Kaplan AP; Austen KF
    J Exp Med; 1971 Apr; 133(4):696-712. PubMed ID: 4251126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IgE-dependent release of a Hageman factor cleaving factor from human lung.
    Meier HL; Flowers B; Silverberg M; Kaplan AP; Newball HH
    Am J Pathol; 1986 Apr; 123(1):146-54. PubMed ID: 3634571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The kinin system of human plasma. V. The probable derivation of prekallikrein activator from activated Hageman factor (XIIa).
    Soltay MJ; Movat HZ; Ozge-Anwar AH
    Proc Soc Exp Biol Med; 1971 Dec; 138(3):952-8. PubMed ID: 5131637
    [No Abstract]   [Full Text] [Related]  

  • 33. Normal plasma arginine esterase and the Hageman factor (factor XII) -prekallikrein-kininogen system in cystic fibrosis.
    Goldsmith GH; Stern RC; Saito H; Ratnoff OD
    J Lab Clin Med; 1977 Jan; 89(1):131-4. PubMed ID: 830773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of Hageman factor and immune complexes.
    Cochrane CG; Wuepper KD; Aiken BS; Revak SD; Spiegelberg HL
    J Clin Invest; 1972 Oct; 51(10):2736-45. PubMed ID: 5056666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation mechanism of human Hageman factor-plasma kallikrein-kinin system by Vibrio vulnificus metalloprotease.
    Miyoshi S; Shinoda S
    FEBS Lett; 1992 Aug; 308(3):315-9. PubMed ID: 1380471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced titers of Hageman factor (factor XII) in Orientals.
    Gordon EM; Donaldson VH; Saito H; Su E; Ratnoff OD
    Ann Intern Med; 1981 Dec; 95(6):697-700. PubMed ID: 7305148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiency.
    Branson HE; Vaziri ND; Slater LM
    J Natl Med Assoc; 1982 Apr; 74(4):339-43. PubMed ID: 7120469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.